Showing results (81-90 of 315) with videos related to
Sort By:
Pageof 32
Seminars in Oncology|June 1, 1988
Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgeryB J Monk, E A Surwit, D S Alberts, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1978
Carnitine prevention of adriamycin toxicity in miceD S Alberts, Y M Peng, T E Moon, et al.Cancer Clinical Trials|January 1, 1981
Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervixD S Alberts, P W Martimbeau, E A Surwit, et al.Investigational New Drugs|January 1, 1984
Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomasT P Miller, S E Jones, D S Alberts, et al.Investigational New Drugs|January 1, 1997
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)J S Macdonald, J K Benedetti, M Modiano, et al.Investigational New Drugs|January 1, 1983
Prospective study of left ventricular function using radionuclide scans in patients receiving mitoxantroneM S Aapro, D S Alberts, J M Woolfenden, et al.Cancer Research|July 1, 1982
Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942)G T Bowden, D Garcia, Y M Peng, et al.British Journal of Cancer|March 1, 1981
Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalanD S Alberts, H G Chen, D Benz, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assayR Ludwig, D S Alberts, T P Miller, et al.Journal of Chromatography|December 10, 1982
Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantroneY M Peng, D Ormberg, D S Alberts, et al.Pageof 32